Google Übersetzer
Tempest Therapeutics, Inc.
About
1.79USD+0.02 +1.13%
Closed • Updated at 07:01 GMT+00:00Market Cap$26.50M
Volume48.1K
Beta2.79
RSI45.31
Tempest Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 14 2026
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
May 6 2026
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting
Apr 29 2026
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting
Apr 22 2026
Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T
Apr 14 2026
Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts
Recent Videos
Tempest Therapeutics (TPST) Bizumentary
May 07, 2026
How Tempest Therapeutics Changed Overnight!
May 02, 2026
Tempest Therapeutics Deep Dive: The $250M Valuation Gap
Mar 28, 2026
23 March 26. Biotech Stock News. Daily Recap2 #English #Shorts $XBI #trading #biotechnews #dailynews
Mar 23, 2026
Community Chat
Ask AI
Try asking